Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
2.
Int J Pharm ; 495(1): 463-473, 2015 Nov 10.
Article in English | MEDLINE | ID: mdl-26362078

ABSTRACT

The aim of this study was to evaluate the osteoinductive capacity of a poloxamine (Tetronic(®) 908, T) and α-cyclodextrin (αCD) supramolecular gel (T-CD) as scaffold in a critical size defect in rat calvaria. The T-CD gel was evaluated solely and after being loaded with simvastatin (SV) and bone morphogenetic protein (BMP-2) separately and in combinations in order to reduce the doses of the active substances. Three doses of SV (7.5, 75, 750 µg) and two doses of BMP-2 (3 and 6 µg) were tested. The histology and histomorphometrical analysis showed improved bone repair with T-CD compared to T, probably due to better release control of both SV and BMP-2. In addition, as T-CD eroded more slowly than poloxamine alone, it remained longer in the defect site. Although synergism was not obtained with BMP-2 and SV, according to the observed regeneration of the defect, the dose of BMP-2 and SV can be reduced to 3 µg and 7.5 µg, respectively.


Subject(s)
Bone Morphogenetic Protein 2/administration & dosage , Bone Regeneration/drug effects , Polyethylene Glycols/administration & dosage , Propylene Glycols/administration & dosage , Simvastatin/administration & dosage , Skull/surgery , alpha-Cyclodextrins/chemistry , Animals , Bone Morphogenetic Protein 2/pharmacology , Dose-Response Relationship, Drug , Drug Combinations , Drug Liberation , Gels/chemistry , Male , Polyethylene Glycols/chemistry , Polyethylene Glycols/pharmacology , Propylene Glycols/chemistry , Propylene Glycols/pharmacology , Rats , Rats, Sprague-Dawley , Simvastatin/pharmacology , Tissue Scaffolds , Viscosity
5.
Cell Mol Biol (Noisy-le-grand) ; 60(1): 19-25, 2014 Mar 05.
Article in English | MEDLINE | ID: mdl-24606724

ABSTRACT

To metastasize distant organs, tumor cells and endothelial cells lining the blood vessels must crosstalk. The nature of this communication that allows metastatic cells to intravasate and travel through the circulation and to extravasate to colonize different organs is poorly understood. In this study, we evaluated one of the first steps in this process­the proximity and physical interaction of endothelial and metastatic cells. To do this, we developed a cell separator chamber that allows endothelial and metastatic cells to grow side by side. We have shown in our previous studies that V-ATPases at the cell surface (pmV-ATPase) are involved in angiogenesis and metastasis. Therefore, we hypothesized that the physical proximity/interaction between endothelial and metastatic cells expressing pmV-ATPase will increase its activity in both cell types, and such activity in turn will increase pmV-ATPase expression on the membranes of both cell types. To determine pmV-ATPase activity we measured the proton fluxes (JH+) across the cell membrane. Our data indicated that interaction between endothelial and metastatic cells elicited a significant increase of JH+ via pmV-ATPase in both cell types. Bafilomycin, a V-ATPase inhibitor, significantly decrease JH+. In contrast, JH+ of the non-metastatic cells were not affected by the endothelial cells and vice-versa. Altogether, our data reveal that one of the early consequences of endothelial and metastatic cell interaction is an increase in pmV-ATPase that helps to acidify the extracellular medium and favors protease activity. These data emphasize the significance of the acidic tumor microenvironment enhancing a metastatic and invasive phenotype.


Subject(s)
Cell Communication , Endothelial Cells/cytology , Neoplasm Metastasis/pathology , Vacuolar Proton-Translocating ATPases/physiology , Cell Line, Tumor , Endothelial Cells/metabolism , Humans , Male , Neovascularization, Pathologic , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/pathology , Tumor Microenvironment , Vacuolar Proton-Translocating ATPases/metabolism
6.
Eur Cell Mater ; 25: 351-65; discussion 365, 2013 Jul 08.
Article in English | MEDLINE | ID: mdl-23832688

ABSTRACT

Full-thickness articular cartilage damage does not resolve spontaneously. Studies with growth factors, implantation of autologous chondrocytes and mesenchymal stem cells have led to variable, to some extent inconsistent, results. This work compares osteochondral knee-defect repair in rabbits upon implantation of a previously described alginate/(poly(lactic-co-glycolic) acid (PLGA) osteochondral scaffold in distinct conditions. Systems were either in vitro pre-cultured with a small number of allogeneic chondrocytes under fibroblast growth factor (FGF)-2 stimulation or the same amount of allogeneic, marrow derived, mesenchymal stem cells (without any pre-differentiation), or loaded with microsphere-encapsulated bone morphogenetic protein (BMP)-2 within the alginate layer, or holding combinations of one or the other cell type with BMP-2. The experimental limit was 12 weeks, because a foregoing study with this release system had shown a maintained tissue response for at least 24 weeks post-operation. After only 6 weeks, histological analyses revealed newly formed cartilage-like tissue, which resembled the adjacent, normal cartilage in cell as well as BMP-2 treated defects, but cell therapy gave higher histological scores. This advantage evened out until 12 weeks. Combinations of cells and BMP-2 did not result in any additive or synergistic effect. Equally efficient osteochondral defect repair was achieved with chondrocyte, stem cell, and BMP-2 treatment. Expression of collagen X and collagen I, signs of ongoing ossification, were histologically undetectable, and the presence of aggrecan protein indicated cartilage-like tissue. In conclusion, further work should demonstrate whether spatiotemporally controlled, on-site BMP-2 release alone could become a feasible therapeutic approach to repair large osteochondral defects.


Subject(s)
Bone Morphogenetic Protein 2/pharmacology , Cartilage, Articular/pathology , Chondrocytes/cytology , Stem Cell Transplantation , Stem Cells/cytology , Wound Healing/drug effects , Animals , Biomarkers/metabolism , Cartilage, Articular/drug effects , Cartilage, Articular/metabolism , Cells, Cultured , Chondrocytes/drug effects , Chondrocytes/metabolism , Lactic Acid/chemistry , Male , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/metabolism , Polyglycolic Acid/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer , Prosthesis Implantation , Rabbits , Regeneration/drug effects , Stem Cells/drug effects , Tissue Scaffolds/chemistry
7.
Med. intensiva (Madr., Ed. impr.) ; 34(7): 476-482, oct. 2010. tab
Article in Spanish | IBECS | ID: ibc-95128

ABSTRACT

Los sistemas de gestión de la calidad permiten priorizar acciones para que se pueda mantener la seguridad y la eficacia de las tecnologías sanitarias. En la Unidad de Cuidados Intensivos (UCI) de nuestro hospital se ha implementado un plan de gestión de la calidad, que ha obtenido el reconocimiento como «Servicio Certificado que gestiona sus actividades según la norma UNE-EN ISO 9001:2008». Con la aplicación del sistema de gestión de la calidad se logra detectar las necesidades que puede cubrir el servicio, esto con el fin de lograr la satisfacción del paciente, familiar o personal sanitario del resto de los servicios del hospital, mejorar las comunicaciones dentro y fuera del servicio, conseguir una mayor comprensión de los procesos de la organización y control de riesgo, delimitar responsabilidades de forma clara a todo el personal, llevar a cabo una mejor utilización del tiempo y los recursos y, por último, mejorar, si cabe, la motivación del personal (AU)


The Quality Management Systems make it possible to prioritize actions to maintain the safety and efficacy of health technologies. The Intensive Care Unit of our hospital has implemented a quality management plan, which has obtained accreditation as «Service Certificate that manages its activities according to UNE-EN ISO 9001:2008» standard. With the application of quality management system, it has been possible to detect the needs that the Service can cover in order to obtain the satisfaction of the patient, relative or health personnel of the other services of the hospital, to improve communications inside and outside of service, to secure greater understanding of the processes of the organization and control of risk, to delimit responsibilities clearly to all the personnel, to make better use of the time and resources and, finally, to improve the motivation of the personnel (AU)


Subject(s)
Humans , 34002 , Intensive Care Units/standards , 51590/analysis , 51706 , Quality Indicators, Health Care
8.
Med Intensiva ; 34(7): 476-82, 2010 Oct.
Article in Spanish | MEDLINE | ID: mdl-20822737

ABSTRACT

The Quality Management Systems make it possible to prioritize actions to maintain the safety and efficacy of health technologies. The Intensive Care Unit of our hospital has implemented a quality management plan, which has obtained accreditation as "Service Certificate that manages its activities according to UNE-EN ISO 9001:2008" standard. With the application of quality management system, it has been possible to detect the needs that the Service can cover in order to obtain the satisfaction of the patient, relative or health personnel of the other services of the hospital, to improve communications inside and outside of service, to secure greater understanding of the processes of the organization and control of risk, to delimit responsibilities clearly to all the personnel, to make better use of the time and resources and, finally, to improve the motivation of the personnel.


Subject(s)
Intensive Care Units/standards , Total Quality Management/standards , Internationality
9.
Urol Int ; 57(2): 104-7, 1996.
Article in English | MEDLINE | ID: mdl-8873367

ABSTRACT

Wilms' tumor (nephroblastoma), a primary renal neoplasm containing primitive blastema and embryonic glomerulotubular structures, is the most common malignant tumor of the urinary tract in children. There have been about 240 cases of adult Wilms' tumor reported in the world literature, however due to some differences in histologic findings, many cases have been reclassified as rhabdoid or clear cell sarcomas, both of which are recognized as separate entities. We report a case of an adult Wilms' tumor and discuss the clinical, radiographic and histologic features of this tumor.


Subject(s)
Kidney Neoplasms/diagnosis , Wilms Tumor/diagnosis , Female , Humans , Kidney/diagnostic imaging , Kidney/pathology , Middle Aged , Tomography, X-Ray Computed
10.
Clin Neuropathol ; 14(4): 187-96, 1995.
Article in English | MEDLINE | ID: mdl-8521620

ABSTRACT

Central nervous system (CNS) abnormalities attributed to direct effects of HIV infection are seen in most of children with acquired immunodeficiency syndrome (AIDS). Secondary CNS infections with opportunistic and common pathogens are infrequent in this age group. We report 9 cases of opportunistic infection of the CNS found among 65 autopsy cases of pediatric AIDS. These included 4 cases of cytomegalovirus (CMV) infection, 1 of which was associated with aspergillosis, and 2 cases of candidiasis, 1 of which coexisted with Mycobacterium avium intracellulare (MAI) infection. There were also 2 cases of leptomeningitis, 1 due to Mycobacterium tuberculosis (MTB) and the other to Cryptococcus neoformans. In 1 child progressive multifocal leukoencephalopathy (PML) coexisted with mycotic encephalitis caused by an Aspergillus sp.


Subject(s)
AIDS-Related Opportunistic Infections/pathology , Central Nervous System Diseases/pathology , Aspergillosis/pathology , Aspergillus flavus , Autopsy , Candidiasis/pathology , Child , Child, Preschool , Cytomegalovirus Infections/pathology , Female , Humans , Infant , Leukoencephalopathy, Progressive Multifocal/pathology , Male , Mycobacterium avium-intracellulare Infection/pathology
12.
J Urol ; 115(2): 209-11, 1976 Feb.
Article in English | MEDLINE | ID: mdl-765504

ABSTRACT

Noonan's syndrome is an eponymic designation that has been used during the last 8 years to describe a variable constellation of somatic and visceral congenital anomalies, which includes groups of patients previously referred to as male Turner's, female pseudo-Turner's and Bonnevie-Ullrich syndromes. It is now recognized that both sexes may show the stigmas of this condition and, unlike Turner's syndrome, there is no karyotype abnormality although there is often a familial pattern. The most commonly observed anomalies include webbing of the neck, hypertelorism, a shield-shaped chest and short stature. Congenital heart disease, principally pulmonary stenosis, and sexual infantilism often with cryptorchidism in the male subject are additional associated anomalies in this syndrome. Renal anomalies have been described rarely and usually consist of rotational errors, duplications and hydronephrosis. We report the first case of an infant who displayed many of the stigmas of Noonan's syndrome and also showed early evidence of frank renal failure secondary to renal dysplasia with cystic disease.


Subject(s)
Polycystic Kidney Diseases/complications , Turner Syndrome/complications , Humans , Infant , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...